Cite
HARVARD Citation
Altman, R. et al. (n.d.). Low-dose SoluMatrix meloxicam results in clinically meaningful improvements in pain in a phase 3 study of patients with osteoarthritis. Osteoarthritis and cartilage. pp. S419-S420. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Altman, R. et al. (n.d.). Low-dose SoluMatrix meloxicam results in clinically meaningful improvements in pain in a phase 3 study of patients with osteoarthritis. Osteoarthritis and cartilage. pp. S419-S420. [Online].